CAS No. |
1392312-45-6 |
|---|---|
中文名称 |
4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-((2-(1,1-二氧化硫代吗啉-4-基)乙基)氨基)-5a,5b,8,8,11a-五甲基-1-(丙-1-烯-2-基)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-十八氢-1H-环戊并[a]屈-9-基)苯甲酸 |
英文名称 |
4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-((2-(1,1-dioxidothiomorpholino)ethyl)amino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)benzoic acid |
别名 |
BMS-955176;BMS-955176 (GSK-3532795;GSK3532795;BMS-955176(free base);GSK-3532795,GSK3532795;Benzoic acid, 4-[17-[[2-(1,1-dioxido-4-thiomorpholinyl)ethyl]amino]-28-norlupa-2,20(29)-dien-3-yl]- |
标准英文名 |
4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-((2-(1,1-dioxidothiomorpholino)ethyl)amino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)benzoic acid |
分子式 |
C42H62N2O4S |
分子量 |
691.03 |
精确分子量 |
690.44 |
SMILES |
C=C(C)[C@@H]1CC[C@]2(NCCN3CCS(=O)(=O)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC=C(C6=CC=C(C(=O)O)C=C6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12 |
标准SMILES |
CC1(C)[C@@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@H]5[C@@H](CC[C@@]5(CC[C@@]34C)NCCN3CCS(=O)(=O)CC3)C(C)=C)[C@@]2(C)CC=C1C1C=CC(=CC=1)C(O)=O |
用途 |
GSK3532795 is a potent, orally bioavailable, second-generation HIV-1 maturation inhibitor; it exhibits EC50 values of 1.9, 10.2, 2.7, and 13 nM against HIV-1WT, HIV-1WT (in human serum), HIV-1V370A, and HIV-1ΔV370, respectively. |
InChIKey |
XDMUFNNPLXHNKA-ZTESCHFWSA-N |
|
|
评论 |
|---|